Clopidogrel and aspirin in the prevention of thromboembolic complications after mechanical aortic valve replacement (CAPTA).
Schlitt
Axel
A
Department of Medicine II, Johannes Gutenberg-University Mainz, Langenbeckstr. 1, 55131 Mainz, Germany. axelschlitt@gmx.net
von Bardeleben
Ralf S
RS
Ehrlich
Anne
A
Eimermacher
Antje
A
Peetz
Dirk
D
Dahm
Manfred
M
Rupprecht
Hans J
HJ
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001021:Aortic Valve / Q000601:surgery; D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects; D000077144:Clopidogrel; D004359:Drug Therapy, Combination; D005260:Female; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D010644:Phenprocoumon / Q000627:therapeutic use*; D010865:Pilot Projects; D013923:Thromboembolism / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D013988:Ticlopidine / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D000077144:Clopidogrel; D013988:Ticlopidine; D010644:Phenprocoumon; D001241:Aspirin